Pantages Capital Acquisition
PGAC · NASDAQ
About PGAC
- Employees
- 0
- Headquarters
- Wilmington, Delaware
- Listed
- Dec 5, 2024
- Sector
- N/A
- Industry
- N/A
PGAC key statistics
- Market cap
- 32.25M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.14K
- Volume
- 220
- Open price
- $10.87
- High today
- $10.82
- Low today
- $10.82
- 52 Week high
- $11.39
- 52 Week low
- $10.30
Pantages Capital Acquisition (PGAC) at a glance
Pantages Capital Acquisition (PGAC) last traded at $10.82, with a market cap of 32.25M and a price-to-earnings ratio of 0.00.
Volume so far is 220 shares, below the average of 1.14K shares a day.
Over the past year Pantages Capital Acquisition has ranged from $10.30 to $11.39, and now sits 48% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- DVLTDatavault AI$0.0879+31.19%
- RCTRedCloud Holdings$0.0617−5.95%
- TIPSTianrong Internet Products & Services$0.0014+27.27%
- GTVHGolden Triangle Ventures$0.0002+0.00%
- AITXArtificial Intelligence Technology Solutions$0.0005−43.75%
- CDTCDT Equity$0.083+3.75%
- EARIEntertainment Arts Research$0.0002+0.00%
- NBNDNetBrands$0.0006−14.29%
- NVDGraniteShares ETF Trust$4.01+2.04%
- STLAStellantis N.V$4.68+13.04%
- NTRRNeutra$0.0002+0.00%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.97−0.05%
- LYCALycia Therapeutics$25.05−4.06%
- DAVIDAVION HEALTHCARE$3.29+9.67%
- TCXBTCGX Acquisition Corp. II$10.27−0.10%
- CTYCITY THERAPEUTICS$21.65+3.79%
- IAMIambic Therapeutics$14.78+5.57%
- AMROAmaero$5.86−2.98%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.23−0.49%
- TRXBTRex Bio$14.43+4.64%
- RTSNRetension Pharmaceuticals$13.09−3.18%
- PAXGUPine Tree Acquisition$10.02+0.20%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.